Bionic strategy-based design of chirality-dependent activity Cu-Trp nanozymes: tight orchestration of the chronic refractory wound healing phase
Nanoscale · 2025
DOI: 10.1039/d5nr02918j ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Shaoxiong Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, P.R. China. yuxixun@163.com. Hauptthemen laut MEDLINE: Wound Healing, Copper, Tryptophan, Metal-Organic Frameworks. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Sichuan University.
Themen: Wundversorgung
Abstract (Originalsprache)
Cu-Trp ( l ) effectively eliminates bacterial infections and reactive oxygen species (ROS) in chronic refractory wounds, while regulating the immune response to promote healing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, P.R. China. yuxixun@163.com.
- Experimental and Research Animal Institute, Sichuan University, Chengdu 610065, P.R. China.
Förderung
- Sichuan University
Zitieren
APA
Feng, S., Peng, X., Pu, X., Gao, X., Deng, Y., Wei, X., & Yu, X. (2025). Bionic strategy-based design of chirality-dependent activity Cu-Trp nanozymes: tight orchestration of the chronic refractory wound healing phase. Nanoscale. https://doi.org/10.1039/d5nr02918j
Vancouver
Feng S, Peng X, Pu X, Gao X, Deng Y, Wei X, et al. Bionic strategy-based design of chirality-dependent activity Cu-Trp nanozymes: tight orchestration of the chronic refractory wound healing phase. Nanoscale. 2025. doi:10.1039/d5nr02918j
BibTeX
@article{Feng2025,
author = {Feng, Shaoxiong and Peng, Xu and Pu, Xinyun and Gao, Xi and Deng, Yiqing and Wei, Xu and Yu, Xixun},
title = {Bionic strategy-based design of chirality-dependent activity Cu-Trp nanozymes: tight orchestration of the chronic refractory wound healing phase},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d5nr02918j}
}
EUVIMED